Ready-to-go viral vector technology platform

exoREADY is a viral vector technology platform providing an off-the-shelf solution for transient expression for both adeno-associated virus (AAV) and lentivirus (LV) compatible with adherent and suspension culture based on a HEK-293 cell line. The platform also provides pre-optimized downstream purification processes, a development analytical toolkit and dedicated in-process and release quality control methods that can address all the steps required for the manufacture of complex advanced therapies in a fast, efficient, and lower cost manner.

Ready-to-go viral vector technology platform

exoREADY is a viral vector technology platform providing an off-the-shelf solution for transient expression for both adeno-associated virus (AAV) and lentivirus (LV) compatible with adherent and suspension culture based on a HEK-293 cell line. The platform also provides pre-optimized downstream purification processes, a development analytical toolkit and dedicated in-process and release quality control methods that can address all the steps required for the manufacture of complex advanced therapies in a fast, efficient, and lower cost manner.

Capitalize on exoREADY technology platform

Viral vector 

dedicated platform

  • EProprietary technology platform
  • EDedicated to industrial manufacturing of viral vectors for C>
  • EFully customizable
  • EHEK293 cell bank

scale-X

bioreactor leader

  • ENew industry gold standard
  • EOne of the most experienced CDMOs
  • ECompleted runs at Exothera: 60+

Ready to use 

technology

  • EState-of-the-art USP equipment
  • EState-of-the-art DSP equipment
  • EPre-developed analytical toolkit
  • ECMC and regulatory support

Capitalize on exoREADY technology platform

Viral vector dedicated platform

  • EProprietary technology platform
  • EDedicated to industrial manufacturing of viral vectors for C>
  • EFully customizable
  • EHEK293 cell bank

scale-X™ bioreactor leader

  • ENew industry gold standard
  • EOne of the most experienced CDMOs
  • ECompleted runs at Exothera: 60+

Ready to use technology

  • EState-of-the-art USP equipment
  • EState-of-the-art DSP equipment
  • EPre-developed analytical toolkit
  • ECMC and regulatory support

Get faster to the clinical phase without quality compromise

We work day by day to reduce the development timeline without compromising on quality and costs. 

Get faster to the clinical phase without quality compromise

We work day by day to reduce the development timeline without compromising on quality and costs.

Bring manufacturing process to GMP

Developed for both adherent and suspension cell culture and equipped with the latest DSP technologies.  

Scalable adherent-based process

We selected scale-X™ technology to bring your adherent-based process from small scale (2.4 m²) to large scale (600 m²). Automated GMP clinical and commercial-scale is ensured by NevoLine™ Upstream platform, which can integrate large scale bioreactor within a 3 m² footprint.

  • Robust, consistent, monitored and fast transfer from flatware processes to  GMP environment
  • High cell density per footprint
  • The fixed-bed architecture acts as a pre-filter, easing the perfusion management without additional devices or equipment  
  • Integrated solution chained processes as in-line clarification and TFF

Scalable suspension-based process

We selected Allegro™ STR Single-use Stirred Tank Bioreactor to bring your suspension-based process from shake flasks to large scale (2000L). Allegro™ STR Single-use Stirred Tank Bioreactor ensures automated GMP clinical and commercial-scale up.

  • Proven robust and agile scalability 
  • Simple tech transfer to client’s facility
  • Scale-down model for process characterization and optimization
  • Continuous processing/perfusion with ATF system
  • Compatible with serum-free and chemically defined media 

For any questions

Please contact us and we will respond quickly!  

For any questions

Please contact us and we will respond quickly!